Table 7.

Correlation of HDAC mRNA expression with progress free survival in different pathological grade ovarian cancer patients.

HDAC	Pathological grade	cases	HR (95% CI)	P value
HDAC1	I	37	0.27(0.09-0.83)	0.014*
	II	256	1.18(0.88-1.58)	0.2658
	III	837	1.11(0.93-1.34)	0.2546
HDAC2	I	28	0.33(0.09-1.24)	0.0858
	II	161	1.31(0.86-1.98)	0.2061
	III	315	1.32(1.02-1.71)	0.0363*
HDAC4	I	28	2.44(0.65-9.2)	0.173
	II	161	1.63(1.13-2.36)	0.0086*
	III	315	1.37(1.05-1.77)	0.0189*
HDAC5	I	28	0.53(0.14-1.96)	0.3301
	II	161	1.24(0.85-1.8)	0.2639
	III	315	1.5(1.14-1.98)	0.0035*
HDAC11	I	28	2.26(0.6-8.46)	0.214
	II	161	1.25(0.85-1.83)	0.2572
	III	315	1.46(1.14-1.89)	0.0032*

*: P<0.05